ES8605098A1 - Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina. - Google Patents

Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina.

Info

Publication number
ES8605098A1
ES8605098A1 ES530439A ES530439A ES8605098A1 ES 8605098 A1 ES8605098 A1 ES 8605098A1 ES 530439 A ES530439 A ES 530439A ES 530439 A ES530439 A ES 530439A ES 8605098 A1 ES8605098 A1 ES 8605098A1
Authority
ES
Spain
Prior art keywords
combination
ligand
enzyme
measuring
antibody against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530439A
Other languages
English (en)
Other versions
ES530439A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3897583A external-priority patent/JPS59164960A/ja
Priority claimed from JP5149483A external-priority patent/JPS59178360A/ja
Priority claimed from JP5149583A external-priority patent/JPS59178361A/ja
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Publication of ES530439A0 publication Critical patent/ES530439A0/es
Publication of ES8605098A1 publication Critical patent/ES8605098A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/969—Multiple layering of reactants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

METODO DE MEDIR LIGANDOS DEL TIPO DE SUSTANCIAS MEDICINALES Y CONSTITUYENTES TRAZAS DERIVADOS DE DIVERSAS ENFERMEDADES EN FLUIDOS CORPORALES. COMPRENDE LAS OPERACIONES: A) PONER EN CONTACTO UN LIGANDO QUE HA DE SER MEDIO Y UNA ENZIMA, O UNA COMBINACION DE UNA ENZIMA Y UNA SUSTANCIA MACROMOLECULAR, CON UN PRODUCTO COMBINADO DE UN ANTICUERPO CONTRA EL LIGANDO Y UN ANTICUERPO CONTRA LA ENZIMA, O CON UN PRODUCTO COMBINADO DE UN ANTICUERPO CONTRA EL LIGANDO, UN ANTICUERPO CONTRA LA ENZIMA Y UNA SUSTANCIA MACROMOLECULAR, EN UNA SOLUCION ACUOSA COMPRENDIDA DENTRO DE LOS INTERVALOS DE 4 A 8,5 DE PH Y DE 20 A 45JC; Y B) MEDIR LA ACTIVIDAD DE LA ENZIMA.
ES530439A 1983-03-11 1984-03-09 Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina. Expired ES8605098A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3897583A JPS59164960A (ja) 1983-03-11 1983-03-11 抗原決定基具有物質の測定法
JP5149483A JPS59178360A (ja) 1983-03-29 1983-03-29 抗原決定基具有物質測定方法
JP5149583A JPS59178361A (ja) 1983-03-29 1983-03-29 抗原決定基具有物質測定法

Publications (2)

Publication Number Publication Date
ES530439A0 ES530439A0 (es) 1986-03-01
ES8605098A1 true ES8605098A1 (es) 1986-03-01

Family

ID=27289998

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530439A Expired ES8605098A1 (es) 1983-03-11 1984-03-09 Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina.

Country Status (4)

Country Link
US (1) US4621048A (es)
EP (1) EP0119767B1 (es)
DE (1) DE3483620D1 (es)
ES (1) ES8605098A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485339D1 (de) * 1983-11-18 1992-01-23 Fujirebio Kk Verfahren zur messung eines biologischen ligands.
US4757001A (en) * 1984-02-16 1988-07-12 Fujirebio Kabushiki Kaisha Method of measuring biological ligand by utilizing amylase
IT1199088B (it) * 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
AU7238087A (en) * 1986-03-26 1987-10-20 Murex Corp. Anti-enzyme antibody immunoassay
DE3852166T2 (de) * 1987-09-30 1995-04-06 Fuji Photo Film Co Ltd Analytische Vorrichtung für enzymimmunologische Tests.
DE3807440A1 (de) * 1988-03-07 1989-09-21 Progen Biotechnik Gmbh Verfahren zum immunologischen nachweis von substanzen sowie eine derartige zusammensetzung und ein testkit
US5178988A (en) * 1988-09-13 1993-01-12 Amp-Akzo Corporation Photoimageable permanent resist
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
ES2148144T3 (es) * 1990-11-20 2000-10-16 Dade Behring Marburg Gmbh Procedimiento para la estabilizacion de conjugados de enzima.
US5565326A (en) * 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
US5916757A (en) * 1994-05-31 1999-06-29 Johnson & Johnson Clinical Diagnostics, Inc. Specific binding assay using enzyme inhibitor and anti-inhibitor antibodies
US5650324A (en) * 1994-05-31 1997-07-22 Johnson & Johnson Clinical Diagnostics, Inc. Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
US5567581A (en) * 1995-03-06 1996-10-22 Diagnostic Reagents, Inc. Method and kit for enzymatically determining the pH of a specimen
US20040157262A1 (en) * 1996-04-30 2004-08-12 Michel Kohl Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
KR20010025027A (ko) * 1998-05-15 2001-03-26 타다시 마츠다 면역측정시약 및 면역측정법
US6306273B1 (en) * 1999-04-13 2001-10-23 Aclara Biosciences, Inc. Methods and compositions for conducting processes in microfluidic devices
SE0400886D0 (sv) * 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
CN110174363A (zh) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
US4160645A (en) * 1977-07-14 1979-07-10 Syva Company Catalyst mediated competitive protein binding assay
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
IL67289A (en) * 1982-03-18 1985-12-31 Miles Lab Homogeneous immunoassay with labeled monoclonal anti-analyte
US4446233A (en) * 1982-05-05 1984-05-01 E. I. Du Pont De Nemours And Company Homogeneous immunoassay using covalent hybrid antibodies
FR2542871B1 (fr) * 1983-03-15 1986-05-16 Pasteur Institut Procede de dosage en phase heterogene de substances biologiques antigeniques, mettant en oeuvre des conjugues hybrides d'anticorps et reactifs pour sa mise en oeuvre

Also Published As

Publication number Publication date
US4621048A (en) 1986-11-04
ES530439A0 (es) 1986-03-01
EP0119767B1 (en) 1990-11-22
DE3483620D1 (de) 1991-01-03
EP0119767A3 (en) 1988-01-27
EP0119767A2 (en) 1984-09-26

Similar Documents

Publication Publication Date Title
ES8605098A1 (es) Metodo de medir ligandos del tipo de substancias medicinales y constituyentes trazos derivados de diversas enfermedades en fluidos corporales tales como suero sanguineo y orina.
DE3476455D1 (en) Polymer catalyst transducers and use thereof in test kits for analytical methods
DE68922390D1 (de) Verfahren und apparat zur messung der effekte von zellwirksamen mitteln auf lebende zellen.
DE3064360D1 (en) Device for delivering measured quantities of reagent to an assay medium and method of assaying a liquid aqueous assay medium
TW369599B (en) A reagent strip and a method for measuring glucose concentration in a sample of whole blood
IE42506L (en) Detection of protein in body fluids
JPS5581597A (en) Glucose indicator * test tool and method for measuring glucose present in liquid
ES8507265A1 (es) Un metodo de medir un ligando biologico
ES8602141A1 (es) Un metodo de medir un ligando biologico
DE3669077D1 (de) Methode zur messung der menge eines immunantikoerpers im serum.
JPS5631648A (en) Test in which cohesion is caused by contact with body fluid containing antigen and method of preparing reagent for said test
JPS54147098A (en) Method of measuring concentration of glucose in body fluid by chemical kinetics
JPS52136689A (en) Sensor for measuring concentration of specific substance in fluid
ES8601309A1 (es) Un metodo de medir un ligando biologico
JPS5663259A (en) Measuring device for blood emergent test item
WO1998046993A3 (en) Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor
EP0350116A3 (en) Electrochemical cell for measuring ionic activity in a solution and its method of use
FR2303290A1 (fr) Detecteur a reactif, son procede de preparation et son application a l'analyse chimique et biochimique
JPS5337077A (en) Probe for tester
JPS5327494A (en) Enzyme analysis and apparatus therefor
GB1301535A (es)
JPS5523989A (en) Measuring of ascorbic acid content in liquid
ATE44823T1 (de) Anordnung zur messung der ex-vivo-blutungszeit.
ES8402876A1 (es) Procedimiento para determinar el nivel de isoenzima dtk en una muestra de fluido corporal o celular humana o animal.
JPS56150356A (en) Immunologic measuring method

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401